FDA approves Johnson & Johnson's ICOTYDE for plaque psoriasis treatment

March 18, 2026 7:50 AM

The U.S. Food and Drug Administration approved ICOTYDE (icotrokinra) for treating moderate-to-severe plaque psoriasis in adults and pediatric patients 12 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found